Sotera Health Company (NASDAQ: SHC) completed a debt refinancing that reduces interest costs on $1.42 billion in term loans, according to a company statement.

The company entered into Amendment No. 7 to its First Lien Credit Agreement on May 20, 2026, with refinancing lenders and JPMorgan Chase Bank as administrative agent. The amendment establishes repriced term loans totaling $1,415,914,725.62.

The refinancing reduces the interest rate spread by 0.25 percentage points across the term loan facility. The repriced loans carry an interest rate of Adjusted Term SOFR plus 2.25% with a 0.00% floor. The company may alternatively elect Alternate Base Rate plus 1.25% or Adjusted Daily Simple SOFR plus 2.25%.

The new loans include a 1.00% premium on certain repricing transactions within six months of the amendment's effective date. The loans amortize at 1.00% annually and mature on May 30, 2031.

Sotera Health Holdings, LLC and certain company subsidiaries participated in the refinancing arrangement alongside the parent company.